| Issue Date | Title | Author(s) |
| 2015 | Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial | Li, Huafang; Yao, Chen; Shi, Jianguo; Yang, Fude; Qi, Shuguang; Wang, Lili; Zhang, Honggeng; Li, Jie; Wang, Chuanyue; Wang, Chuansheng; Liu, Cui; Li, Lehua; Wang, Qiang; Li, Keqing; Luo, Xiaoyan; Gu, Niufan |
| 2016 | Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial | Li, Huafang; Gu, Niufan; Zhang, Hongyan; Wang, Gang; Tan, Qingrong; Yang, Fude; Ning, Yuping; Zhang, Honggeng; Lu, Zheng; Xu, Xiufeng; Shi, Jianguo; Gao, Chengge; Li, Lingjiang; Zhang, Kerang; Tian, Hongjun; Wang, Xiaoping; Li, Keqing; Li, Huichun; Xu, Yi; Xie, Shiping; Yu, Xin |
| 2010 | INTRAMUSCULAR ZIPRASIDONE HAS IMPROVED TOLERABILITY OVER HALOPERIDOL AND COMPARABLE EFFICACY FOR CONTROL OF AGITATION IN SCHIZOPHRENIA IN CHINESE PATIENTS | Shu, Liang; Zhang, Hongyan; Wang, Gang; Zhao, Jingping; Xie, Shiping; Xu, Xiufeng; Shi, Jianguo; Deng, Hehuang; Li, Keqing; Gao, Chengge; Wang, Xiaoping; Karayal, Onur; Vanderburg, Douglas; Pan, Sharon; Tang, Haiyun |
| 2013 | Intramuscular Ziprasidone Versus Haloperidol for Managing Agitation in Chinese Patients With Schizophrenia | Zhang, Hongyan; Wang, Gang; Zhao, Jingping; Xie, Shiping; Xu, Xiufeng; Shi, Jianguo; Deng, Hehuang; Li, Keqing; Gao, Chengge; Wang, Xiaoping; Vanderburg, Douglas; Pan, Sharon; Tang, Haiyun; Shu, Liang; Karayal, Onur N. |
| 2015 | The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China | Shi, Chuan; Kang, Lan; Yao, Shuqiao; Ma, Yibin; Li, Tao; Liang, Ying; Cheng, Zhang; Xu, Yifeng; Shi, Jianguo; Xu, Xiufeng; Zhang, Congpei; Franklin, Donald R.; Heaton, Robert K.; Jin, Hua; Yu, Xin |
| Jan-2020 | Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia | Feng, Yuan; Shi, Jianguo; Wang, Lili; Zhang, Xia; Tan, Yunlong; Zhao, Jingyuan; Ning, Yuping; Xie, Shiping; Liu, Xuejun; Liu, Qi; Li, Keqing; Wang, Xiaoliang; Li, Lehua; Xu, Xiufeng; Deng, Wei; Luo, Xiaoyan; Wang, Gang |
| 2016 | Safety and efficacy of paliperidone extendedrelease in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study | Zhang, Hongyan; Li, Huafang; Liu, Yanning; Wu, Cathy; Wu, Qingqi; Nuamah, Isaac; Shi, Jianguo; Xie, Shiping; Wang, Gang; Gopal, Srihari |
| 2019 | What is the optimal neuropsychological test battery for schizophrenia in China? | Shi, Chuan; Kang, Lan; Yao, Shuqiao; Ma, Yibin; Li, Tao; Liang, Ying; Cheng, Zhang; Xu, Yifeng; Shi, Jianguo; Xu, Xiufeng; Zhang, Congpei; Franklin, Donald R.; Heaton, Robert K.; Jin, Hua; Yu, Xin |
